BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 10995862)

  • 21. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
    Delaney JA; Opatrny L; Brophy JM; Suissa S
    CMAJ; 2007 Aug; 177(4):347-51. PubMed ID: 17698822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption.
    Kaufman DW; Kelly JP; Wiholm BE; Laszlo A; Sheehan JE; Koff RS; Shapiro S
    Am J Gastroenterol; 1999 Nov; 94(11):3189-96. PubMed ID: 10566713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upper gastrointestinal bleeding associated with antiplatelet drugs.
    Ibáñez L; Vidal X; Vendrell L; Moretti U; Laporte JR;
    Aliment Pharmacol Ther; 2006 Jan; 23(2):235-42. PubMed ID: 16393302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
    Biskupiak JE; Brixner DI; Howard K; Oderda GM
    J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsteroidal antiinflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysis.
    Jankovic SM; Aleksic J; Rakovic S; Aleksic A; Stevanovic I; Stefanovic-Stoimenov N; Radosavljevic M; Kostic M; Tesic D; Petrovic B
    J Nephrol; 2009; 22(4):502-7. PubMed ID: 19662606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study.
    Massó González EL; García Rodríguez LA
    Aliment Pharmacol Ther; 2008 Sep; 28(5):629-37. PubMed ID: 18616644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
    Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT
    Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.
    Lanas Á; Carrera-Lasfuentes P; Arguedas Y; García S; Bujanda L; Calvet X; Ponce J; Perez-Aísa Á; Castro M; Muñoz M; Sostres C; García-Rodríguez LA
    Clin Gastroenterol Hepatol; 2015 May; 13(5):906-12.e2. PubMed ID: 25460554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute upper gastrointestinal bleeding in Jerusalem 1988-91: causes, characteristics and relation to nonsteroidal anti-inflammatory drugs.
    Zimmerman J; Arnon R; Ligumski M; Beeri R; Keret D; Lysy J; Fich A; Tsvang E; Siguencia J; Gonzalez J
    Isr J Med Sci; 1993 May; 29(5):292-7. PubMed ID: 8314690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the risk factors for colonic diverticular hemorrhage.
    Yamada A; Sugimoto T; Kondo S; Ohta M; Watabe H; Maeda S; Togo G; Yamaji Y; Ogura K; Okamoto M; Yoshida H; Kawabe T; Kawase T; Omata M
    Dis Colon Rectum; 2008 Jan; 51(1):116-20. PubMed ID: 18085336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users.
    Coté GA; Rice JP; Bulsiewicz W; Norvell JP; Christensen K; Bobb A; Postelnick M; Howden CW
    Am J Gastroenterol; 2008 May; 103(5):1097-103. PubMed ID: 18477341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
    Battistella M; Mamdami MM; Juurlink DN; Rabeneck L; Laupacis A
    Arch Intern Med; 2005 Jan; 165(2):189-92. PubMed ID: 15668365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs.
    Papatheodoridis GV; Papadelli D; Cholongitas E; Vassilopoulos D; Mentis A; Hadziyannis SJ
    Am J Med; 2004 May; 116(9):601-5. PubMed ID: 15093756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study.
    Hallas J; Dall M; Andries A; Andersen BS; Aalykke C; Hansen JM; Andersen M; Lassen AT
    BMJ; 2006 Oct; 333(7571):726. PubMed ID: 16984924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of and risk factors for upper gastrointestinal complications in patients taking low-dose aspirin in Japan.
    Fujisawa N; Inamori M; Endo H; Uchiyama T; Hosono K; Akiyama T; Tomimoto A; Koyama S; Sawabe A; Tanida E; Yanagisawa S; Hata Y; Okada K; Atsukawa K; Watanabe S; Kawamura H; Higurashi T; Nagase H; Akimoto K; Matsuhashi N; Nakajima A
    Hepatogastroenterology; 2011; 58(105):229-34. PubMed ID: 21510320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review.
    Shiotani A; Manabe N; Kamada T; Fujimura Y; Sakakibara T; Haruma K
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():8-12. PubMed ID: 22486865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.